7,8-Dihydroxyflavone

CAS No. 38183-03-8

7,8-Dihydroxyflavone( 7,8-Dihydroxyflavone | DHF )

Catalog No. M18494 CAS No. 38183-03-8

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
10MG 29 In Stock
50MG 63 In Stock
100MG 84 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7,8-Dihydroxyflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.
  • Description
    7,8-Dihydroxyflavone is an agonist of tyrosine receptor kinase B (TrkB). It acts by promoting immature neuron survival after TBI through activation of the BDNF signaling pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    7,8-Dihydroxyflavone | DHF
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    TrkB
  • Research Area
    Metabolic Disease|Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    38183-03-8
  • Formula Weight
    254.24
  • Molecular Formula
    C15H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 393.33 mM
  • SMILES
    c1ccc(cc1)c1cc(=O)c2c(o1)c(c(cc2)O)O
  • Chemical Name
    7,8-Dihydroxy-2-phenyl-chromen-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee RH, et al. Oncol Rep. 2015 Feb;33(2):631-8.
molnova catalog
related products
  • (Rac)-JBJ-04-125-02

    JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.

  • Epidermal Growth Fac...

    Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.

  • HER2/neu (654-662) G...

    Affibody (affibody) ligands that are specific for the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) have been selected by phage display technology from a combinatorial protein library based on the 58 amino acid residue staphylococcal protein A-derived Z domain.